Anixa Biosciences (ANIX) Stock Statistics & Valuation Metrics

Anixa Biosciences has a market cap or net worth of $108.63M. The enterprise value is ―.

Anixa Biosciences has 32,916,916 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anixa Biosciences’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -72.34%.

The current PE Ratio of Anixa Biosciences is ―. Anixa Biosciences’s PEG ratio is -0.41.

In the last 12 months, Anixa Biosciences had revenue of 0.00 and earned -12.55M in profits. Earnings per share was -0.39.

In the last 12 months, operating cash flow was -6.84M and capital expenditures 0.00, giving a free cash flow of -6.84M billion.

Anixa Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Anixa Biosciences upcoming earnings date is Mar 8, 2024, TBA (Confirmed).

Anixa Biosciences as a current ratio of 8.54, with Debt / Equity ratio of 1.28%

In the past 12 months, Anixa Biosciences has paid 0.00 in taxes.

Anixa Biosciences EV to EBITDA ratio is -8.74, with an EV/FCF ratio of -15.08.

Anixa Biosciences has $16.03M in cash and marketable securities with $213.00K in debt, giving a net cash position of $15.82M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Anixa Biosciences is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy